Fidelis Insurance Holdings Limited (NYSE:FIHL) reached a new 52-week high on January 7, 2024, trading at $20.00 before closing at $19.89. This marks a significant increase from its previous close of $19.72, with a trading volume of 16,764 shares. The rise in stock price comes amid a series of positive analyst ratings and recommendations.
Analysts Set New Price Targets
A number of financial analysts have recently revised their price targets for Fidelis Insurance. According to a research note from Evercore, the target price was set at $21.00. Similarly, UBS Group raised their price objective on January 6 from $23.00 to $24.00, maintaining a “buy” rating for the company.
Other notable updates include Weiss Ratings reaffirming a “hold (c)” rating on December 29, while Keefe, Bruyette & Woods also increased their target from $23.00 to $24.00. The Goldman Sachs Group has set a more conservative price target of $17.50. Currently, four research analysts rate the stock as a Buy, four as a Hold, and two as a Sell, resulting in an average rating of “Hold” and an average target price of $21.93, according to data from MarketBeat.com.
Recent Earnings and Institutional Activity
Fidelis Insurance last reported earnings results on November 12, 2024, revealing earnings per share of $1.21 for the quarter, slightly surpassing analysts’ expectations of $1.19 by $0.02. Despite this positive outcome, the company reported a negative net margin of 0.56% and a negative return on equity of 0.94%. The revenue for the quarter stood at $651.90 million, falling short of the estimated $676.79 million.
In recent months, institutional investors have been active in modifying their holdings in Fidelis Insurance. North Capital Inc. acquired a new stake valued at approximately $33,000 during the second quarter, while Focus Partners Wealth added a stake worth $77,000 in the third quarter. Additionally, Ameritas Investment Partners Inc. increased its stake by 15.3%, now holding 6,088 shares valued at $101,000 after acquiring an additional 810 shares. CWM LLC significantly grew its holdings by 444.4%, possessing 7,131 shares worth $118,000 after purchasing an extra 5,821 shares. Meanwhile, Tower Research Capital LLC boosted its position by 58.9%, owning 7,786 shares valued at $129,000.
Institutional investors and hedge funds collectively own approximately 81.99% of the company’s stock, indicating strong institutional confidence in Fidelis Insurance.
Fidelis Insurance Holdings Limited, incorporated in Bermuda, operates as a specialty insurer and reinsurer, focusing on a broad range of liability and property risks. Since its initial public offering in 2016, the company has been committed to providing tailored solutions for complex risks that traditional insurers may struggle to accommodate. Leveraging data analytics and underwriting expertise, Fidelis develops policies across various industry sectors, including casualty lines, property, marine, energy, and specialty programs.
In a rapidly evolving insurance landscape, Fidelis Insurance’s recent stock performance and analyst upgrades highlight its potential for growth and resilience, appealing to both individual and institutional investors alike.
